Ads
related to: approved varroa treatments uk list
Search results
Results From The WOW.Com Content Network
THYMOVAR is a product to control the Varroa mite (Varroa destructor) on bees (Apis mellifera) and contains the essential oil thymol. THYMOVAR contains thymol, a volatile substance which sublimates in the air depending on temperature. On release, thymol vapour concentrations build up in the treated beehive.
Strimvelis: treatment for adenosine deaminase deficiency (ADA-SCID) Talimogene laherparepvec (Imlygic): treatment for melanoma in patients who have recurring skin lesions [17] Tisagenlecleucel (Kymriah): treatment for B cell lymphoblastic leukemia [18] Valoctocogene roxaparvovec (Roctavian): treatment for hemophilia A [19] [20] [21]
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
It is known that thymol, a compound produced by thyme, naturally occurring in thyme honey, is a treatment for Varroa, though it may cause bee mortality at high concentrations. [2] Provisioning active colonies with crops of thyme may provide the colony with a non-interventional chemical defense against Varroa. [citation needed]
Varroa destructor on the head of bee pupa. Varroa sensitive hygiene (VSH) is a behavioral trait of honey bees (Apis mellifera) in which bees detect and remove bee pupae that are infested by the parasitic mite Varroa destructor. V. destructor is considered to be the most dangerous pest problem for honey bees worldwide. VSH activity results in ...
Varroa is a genus of parasitic mesostigmatan mites associated with honey bees, placed in its own family, Varroidae. [4] The genus was named for Marcus Terentius Varro , a Roman scholar and beekeeper.
Antisense therapy is a form of treatment that uses antisense oligonucleotides (ASOs) to target messenger RNA (mRNA). ASOs are capable of altering mRNA expression through a variety of mechanisms, including ribonuclease H mediated decay of the pre-mRNA, direct steric blockage, and exon content modulation through splicing site binding on pre-mRNA. [1]
Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...